Flagship Pioneering, a bioplatform innovation company, has joined forces with the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine), National University Hospital (NUH), and the National University Health System (NUHS) to advance research and development in human health and sustainability. This collaboration, formalised through a Memorandum of Understanding signed this week, will focus on creating and co-developing research projects over the next five years.
The partnership will leverage Flagship’s ecosystem of over 40 companies, alongside future ventures, to foster innovation. It will also provide career development opportunities for NUS Medicine scientists and students through secondments, internships, and participation in the Flagship Fellowship programme. Additionally, Flagship will utilise clinical data from NUH and NUHS to gain new biological insights and test clinical hypotheses.
André Andonian, Chair of Asia Pacific and Strategic Adviser at Flagship Pioneering, stated, “Our collaboration with NUS Medicine, NUH, and NUHS will help us realise our goal to expand the global reach and impact of Flagship and its companies and serve as an anchor in Singapore and throughout Asia Pacific for globally connected life science innovation.”
Professor Chong Yap Seng, Dean of NUS Medicine, highlighted the potential of this partnership to drive innovation and bridge the gap between discovery and patient care, ultimately benefiting patients and communities worldwide.
This collaboration is expected to significantly contribute to Singapore’s biotech ecosystem, potentially leading to breakthroughs that impact both patients and the planet.
“`
